Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Arie Belldegrun currently holds 10,000 shares of Allogene Therapeutics, Inc. (ALLO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Arie Belldegrun has been a net buyer of ALLO stock. They have purchased $21.2M and sold $4.9M worth of shares.
Arie Belldegrun's most recent insider trade was on Aug 6, 2024, when they sold 10,000 shares at $0.00 per share.
Arie Belldegrun serves as Executive at Allogene Therapeutics, Inc. (ALLO). They have executed 119 insider transactions totaling $26.1M over their tenure at the company.
Arie Belldegrun holds the position of Executive at Allogene Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Arie Belldegrun has shown a buying trading pattern, with $21.2M in total purchases and $4.9M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Arie Belldegrun was on Oct 3, 2017, when they sold $289.4M worth of KITE shares. This transaction involved 1,607,750 shares at $180.00 per share.
Arie Belldegrun currently owns 10,000 shares of Allogene Therapeutics, Inc. (ALLO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Arie Belldegrun's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Arie Belldegrun has 119 Form 4 filings on record as an insider at Allogene Therapeutics, Inc..
Set alerts for Arie Belldegrun and 40,000+ other insiders.